Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2005

View Archived Issues

Methylene blue increases brain oxygen consumption and facilitates memory retention in rats

Neuroprotective effects of S-34176, a free radical scavenger

Chronic gamma-secretase blockade safe and beneficial in experimental AD / News in Context

TheraQuest pain drug candidates investigated in preclinical, clinical studies

(-)-BPAP HCl neuroprotective in organotypic slice cultures

A phase III trial finds no efficacy for edifoligide in the prevention of CABG failure

NuvaRing reported as effective as an oral combination of contraceptives

Clinical evidence supports the use of laquinimod in multiple sclerosis

Gaboxadol shows promise in the treatment of insomnia in elderly subjects

Studies reveal therapeutic value of pregabalin in treating neuropathic pain

ALGRX-4975 reduces pain in osteoarthritis, bunionectomy

Orphan medicinal product status for TGN-1412 in Europe

Maruho and Toray Industries to jointly develop TRK-820 in Japan

Topical anesthesia with ALGRX-3268 tested in children undergoing venipuncture

Keppra effective in adjunctive treatment of myoclonic seizures

Sativex improves pain and symptoms in multiple sclerosis

Serono licenses Syntonix' technologies to develop inhalable interferon-beta:Fc

New patents disclose therapeutic agents for cancer

Novel immunomodulatory agents disclosed by CNRS and INSERM

Recent patents describe new antiinfective compounds

Past Tysabri patient had PML

ImmunoGen submits IND for huC242-DM4

Aeras and Statens Serum Institut team up on TB vaccine development

Enrollment completed in U.S. Fluviral study

ExCel study to investigate ability of exemestane to prevent breast cancer

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...